Novo Nordisk A/S Congress Trades
NYSE: NVOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 4
- Sales
- 4
- Politicians trading
- 5
- Latest trade
- Sep 10, 2026
Novo Nordisk A/S Congress trading summary
Members of Congress have disclosed 43 transactions in Novo Nordisk A/S (NVO) stock, reported by 19 politicians. Over the past 12 months there were 4 purchases and 4 sales. The most active traders over the past year are Rep. Lisa C. McClain (3), Rep. Kevin Hern (2), Rep. Scott Franklin (1).
The latest reported trade is a sale by Kevin Hern dated Sep 10, 2026 and disclosed on Sep 25, 2026. The most common reported amount is $1,001 – $15,000; disclosures list value ranges, not exact amounts.
Summary generated from market data by MetaCap's automated system. Methodology
Politicians trading NVO
Scott FranklinR-FL7 trades7B / 0S
Lisa C. McClainR-MI7 trades3B / 4S
Marjorie Taylor GreeneR-GA3 trades3B / 0S
Katherine M. ClarkD-MA3 trades2B / 1S
Kevin HernR-OK2 trades0B / 2S
Byron DonaldsR-FL2 trades0B / 2S
John JamesR-MI2 trades1B / 1S
Daniel S. GoldmanD-NY2 trades0B / 2S- Nuria Fernandez2 trades2B / 0S
NVO trades by members of Congress
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction.
Related
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction. Disclosures are shown as filed and are not a recommendation to buy or sell NVO. How Congress trading data works